HSBC Reaffirms "Hold" Rating for AstraZeneca plc

HSBC Reaffirms "Hold" Rating for AstraZeneca plc


's stock had its "hold" rating reissued by equities research analysts at HSBC in a research report issued to clients and investors on Thursday, Analyst Ratings.Net reports. They presently have a GBX 4,350 price target on the biopharmaceutical company's stock.



from Biotech News